User profiles for Susan R. Kahn

Susan R Kahn

Professor of Medicine, Canada Research Chair, McGill University
Verified email at mcgill.ca
Cited by 51061

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …

…, PS Wells, MK Gould, F Dentali, M Crowther, SR Kahn - Chest, 2012 - Elsevier
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A), …

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines

C Kearon, SR Kahn, G Agnelli, S Goldhaber… - Chest, 2008 - Elsevier
This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 …

Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …

SR Kahn, W Lim, AS Dunn, M Cushman, F Dentali… - Chest, 2012 - Elsevier
… Author links open overlay panel Susan R. Kahn MD a , Wendy Lim MD b , Andrew S.
Dunn MD e , Mary Cushman MD f , Francesco Dentali MD g , Elie A. Akl MD, MPH, PhD d h , …

Thrombophilic disorders and fetal loss: a meta-analysis

E Rey, SR Kahn, M David, I Shrier - The Lancet, 2003 - thelancet.com
Background Our aim was to assess the strength of the controversial association between
thrombophilia and fetal loss, and to examine whether it varies according to the timing or …

[HTML][HTML] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

…, P van Nguyen, C Demers, SR Kahn… - … England Journal of …, 2003 - Mass Medical Soc
Background Warfarin is very effective in preventing recurrent venous thromboembolism but
is also associated with a substantial risk of bleeding. After three months of conventional …

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis

SR Kahn, I Shrier, JA Julian, T Ducruet… - Annals of internal …, 2008 - acpjournals.org
Background: The reason some patients with deep venous thrombosis (DVT) develop the
postthrombotic syndrome is not well understood. Objective: To determine the frequency, time …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

…, D Diuguid, DO Griffin, SR Kahn… - Blood …, 2021 - ashpublications.org
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence-…

Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial

DR Anderson, SR Kahn, MA Rodger, MJ Kovacs… - Jama, 2007 - jamanetwork.com
ContextVentilation-perfusion (/) lung scanning and computed tomographic pulmonary
angiography (CTPA) are widely used imaging procedures for the evaluation of patients with …

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

MA Rodger, SR Kahn, PS Wells, DA Anderson… - Cmaj, 2008 - Can Med Assoc
Background: Whether to continue oral anticoagulant therapy beyond 6 months after an “unprovoked”
venous thromboembolism is controversial. We sought to determine clinical …

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial

SR Kahn, S Shapiro, PS Wells, MA Rodger, MJ Kovacs… - The Lancet, 2014 - thelancet.com
Background Post-thrombotic syndrome (PTS) is a common and burdensome complication
of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression …